EWTX
Edgewise Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Edgewise Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Fund move
Fund move
−1.27%
vs ±11.6% implied · ×0.11
shaded = implied · ▲▼ = realized
Edgewise Therapeutics, Inc.
39.06
No thesis.
Largest filed tie
—
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Orbimed AdvisorsOrbimed | $630.5M | 12.96% | 0.00% | |
| 2 | Paradigm Biocapital AdvisorsParadigm Biocapital | $415.1M | 8.53% | +38.70% | |
| 3 | RA Capital ManagementRA Capital Management | $341.0M | 7.01% | −19.52% | |
| 4 | BlackRockBlackRockindex-like | $268.4M | 5.52% | +2.06% | |
| 5 | Jupiter TopcoJupiter Topco | $246.9M | 5.08% | — | |
| 6 | FMRFMR | $223.0M | 4.59% | +439.71% | |
| 7 | NovoNovo | $217.4M | 4.47% | 0.00% | |
| 8 | Driehaus Capital ManagementDriehaus | $192.1M | 3.95% | +5.60% | |
| 9 | Perceptive AdvisorsPerceptive | $177.7M | 3.65% | −1.13% | |
| 10 | Vanguard Capital ManagementVanguardindex-like | $156.9M | 3.22% | +1.91% | |
| 11 | Baker Bros. AdvisorsBaker Bros. | $150.4M | 3.09% | −43.71% | |
| 12 | SirenSiren | $129.4M | 2.66% | −28.12% | |
| 13 | Cormorant Asset ManagementCormorant | $102.0M | 2.10% | −23.01% | |
| 14 | Geode Capital ManagementGeodeindex-like | $88.3M | 1.82% | +21.47% | |
| 15 | AlliancebernsteinAlliancebernstein | $86.1M | 1.77% | +23.04% | |
| 16 | Integral Health Asset ManagementIntegral Health | $81.3M | 1.67% | +25.00% | |
| 17 | BraidwellBraidwell | $81.1M | 1.67% | −14.94% | |
| 18 | Morgan StanleyMorgan Stanley | $79.2M | 1.63% | −13.24% | |
| 19 | State StreetState Streetindex-like | $74.3M | 1.53% | +6.47% | |
| 20 | MPM Oncology Impact ManagementMPM Oncology Impact | $65.9M | 1.35% | −2.40% | |
| 21 | Bank of AmericaBank of America | $63.3M | 1.30% | +17.40% | |
| 22 | Qube Research & TechnologiesQube Research & Technologies | $50.9M | 1.05% | +51.65% | |
| 23 | Dimensional Fund AdvisorsDimensional | $46.3M | 0.95% | −6.56% | |
| 24 | American Century CompaniesAmerican Century Companies | $45.8M | 0.94% | −1.75% | |
| 25 | First Light Asset ManagementFirst Light | $44.5M | 0.91% | +9.32% |
228 managers report $4.9B of Edgewise Therapeutics on form 13F for the quarter ended Jun 30 '26. 22 of them hold 80% of it; Orbimed is largest at 12.96%.
Expected move
Inputs8Q avg ±2.4%·×2.99·rich
straddle ±12.5%
spot 38.90exp Nov 20ATM strike 39ATM straddle 5.70IV 77%